Top Story

BenevolentAI raises $115 million for AI enabled drug development

BenevolentAI have announced that it has raised $115 million from new and existing investors

Read more

FDA has approved Tagrisso for 1st-line treatment of metastatic cell lung cancer...

Read more

Ultragenyx Pharmaceutical and Kyowa Kirin International announce FDA approved Crysvita®...

Read more

Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,...

Read more

Novartis announces a five-year commitment to the fight against malaria and invest 100M...

Read more

A community pharmacy supports patients with long-term conditions to improve QOL and reduce cost....

Read more

FDA has approved Rubraca® for the treatment of ovarian, fallopian tube, or primary peritoneal cance...

Read more

Certara announced it has acquired Analytica Laser which uses health economics and outcomes research...

Read more

Apitope,have announced positive results from the clinical trial of ATX-GD-59 Graves' disease....

Read more

new analysis demonstrates Entresto helps preserve kidney function in chronic heart failure...

Read more

Merck partnered with Oxford University's Jenner Institute to develop vaccine manufacturing processes...

Read more